Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. The effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). Rationale and study design

Vicky Chalos, Rob A. van de Graaf, Bob Roozenbeek*, Adriaan C. G. M. van Es, Heleen M. den Hertog, Julie Staals, Lukas van Dijk, Sjoerd F. M. Jenniskens, Robert J. van Oostenbrugge, Wim H. van Zwam, Yvo B. W. E. M. Roos, Charles B. L. M. Majoie, Hester F. Lingsma, Aad van der Lugt, Diederik W. J. Dippel, MR CLEAN MED Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number644
Number of pages17
JournalTrials
Volume21
Issue number1
DOIs
Publication statusPublished - 14 Jul 2020

Keywords

  • Ischemic stroke
  • Acetylsalicylic acid
  • Heparin
  • Cerebrovascular disorders
  • Randomized controlled trial
  • Endovascular treatment
  • Thrombectomy
  • Periprocedural
  • INFORMED-CONSENT PROCEDURE
  • FOCAL CEREBRAL-ISCHEMIA
  • INTRACRANIAL HEMORRHAGE
  • INTRAARTERIAL TREATMENT
  • DEFERRED CONSENT
  • NO-REFLOW
  • OCCLUSION
  • REPERFUSION
  • THERAPY
  • INJURY

Cite this